Teleport Pharmaceuticals is developing PACAP glycopeptides for the treatment of ischemic stroke. See more by clicking on the below image. University of Arizona's news release about the PACAP …
Glycopeptide Drugs: A Pharmacological Dimension Between “Small Molecules” and Biologics
This recent review article highlights the evolution of Teleport Pharmaceutical Founder Professor Robin Polt's groundbreaking work in synthetic approaches of peptide glycosylation. New methods and …
Polt Presentation at ACDD
ACDD Symposium University of Arizona - College of Pharmacy A recording of the June 30th Symposium may be viewed by clicking HERE. Move the video playback bar to the 3:28:40 mark …